Skip to main content
. 2020 Apr;8(8):541. doi: 10.21037/atm.2020.02.113

Figure 2.

Figure 2

Kaplan-Meier survival curves among different groups according to patients’ NLR level. (A) Patients with high NLR vs. patients with low NLR at baseline; (B) patients with high NLR vs. patients with low NLR at three days after TACE; (C) patients with high NLR vs. patients with low NLR at one month after TACE. NLR, platelet-to-lymphocyte ratio; TACE, transarterial chemoembolization.